C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
AssigneeAgensys, Inc.
InventorsDaniel E. H. Afar, Rene S. Hubert, Aya Jakobovits, Arthur B. Raitano
Life of this patent
Estimating the term…
Abstract
The abstract isn’t available for this document.
Claims13
A method to inhibit growth of or inhibit metastases of cancer cells that express PC-LECTIN, which method comprises contacting said cells with an antibody or fragment thereof that specifically binds to PC-LECTIN, wherein said PC-LECTIN has the amino acid sequence shown herein as SEQ. ID. NO:
- 2.
A method to treat a subject for a cancer that expresses PC-LECTIN, which method comprises administering to said subject an antibody or fragment thereof that binds specifically to PC-LECTIN or a nucleic acid molecule comprising nucleotide sequence encoding said antibody or fragment, wherein said PC-LECTIN has the amino acid sequence shown herein as SEQ. ID. NO:
- 2.
Dependencies are inferred from the claim text.